Daniel Zingg

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

SMAD signaling promotes melanoma metastasis independently of phenotype switching.

SMAD signaling promotes melanoma metastasis independently of phenotype switching.

Journal: The Journal of clinical investigation
Published: May 01, 2019

Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation.

Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation.

Journal: Cell stem cell
Published: November 29, 2018

Rare, yet relevant tumor cells - A new twist to melanoma cell plasticity.

Rare, yet relevant tumor cells - A new twist to melanoma cell plasticity.

Journal: Pigment cell & melanoma research
Published: September 13, 2017

EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.

EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.

Journal: Cancer cell
Published: June 26, 2017

The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy.

The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy.

Journal: Cell reports
Published: May 04, 2016

Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2.

Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2.

Journal: Science translational medicine
Published: December 02, 2015

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.

Journal: Genome biology
Published: October 14, 2014

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

Journal: PLoS genetics
Published: September 30, 2014

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

Journal: Nature communications
Published: May 09, 2014

Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.

Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.

Journal: Nature cell biology
Published: March 29, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026